VAM
Visium Asset Management Portfolio holdings
AUM
$955M
This Quarter Return
-11.36%
1 Year Return
-4.5%
3 Year Return
+94.87%
5 Year Return
–
10 Year Return
–
AUM
$6.92B
AUM Growth
+$6.92B
(-1.7%)
Cap. Flow
+$757M
Cap. Flow
% of AUM
10.95%
Top 10 Holdings %
Top 10 Hldgs %
29.22%
Holding
1,353
New
294
Increased
254
Reduced
236
Closed
513
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$271M |
| 2 |
Cigna
CI
|
$140M |
| 3 |
ENDP
Endo International plc
ENDP
|
$103M |
| 4 |
Pacira BioSciences
PCRX
|
$96M |
| 5 |
Tenet Healthcare
THC
|
$70.8M |
Top Sells
| 1 |
Esperion Therapeutics
ESPR
|
$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
$56.3M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$49.4M |
| 4 |
Skechers
SKX
|
$46.3M |
| 5 |
Perrigo
PRGO
|
$45.2M |
Sector Composition
| 1 | Healthcare | 53.77% |
| 2 | Financials | 7.5% |
| 3 | Consumer Discretionary | 6.32% |
| 4 | Energy | 5.47% |
| 5 | Industrials | 5.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENDP
1
DELISTED
Endo International plc
ENDP
| $361M | 4.92% | 5,204,000 +1,493,276 | +40% | +$103M |
|
2
Labcorp
LH
$23.1B
| $327M | 4.47% | 3,018,978 -354,646 | -11% | -$38.5M |
|
|
3
Perrigo
PRGO
$3.27B
| $284M | 3.88% | 1,804,056 -287,385 | -14% | -$45.2M |
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $271M | 3.7% | +997,201 | New | +$271M |
|
5
Bausch Health
BHC
$2.74B
| $184M | 2.51% | 1,031,942 +200,525 | +24% | +$35.8M |
|
|
6
Cigna
CI
$80.3B
| $140M | 1.91% | +1,037,712 | New | +$140M |
|
|
7
Pacira BioSciences
PCRX
$1.2B
| $121M | 1.66% | 2,951,384 +2,336,584 | +380% | +$96M |
|
8
McKesson
MCK
$85.4B
| $118M | 1.61% | 638,054 +364,679 | +133% | +$67.5M |
|
9
CONMED
CNMD
$1.68B
| $112M | 1.53% | 2,338,894 -1,106 | -0% | -$52.8K |
|
|
AET
10
DELISTED
Aetna Inc
AET
| $103M | 1.4% | 939,759 -290,508 | -24% | -$31.8M |
|
|
MNTA
11
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $88.6M | 1.21% | 5,398,088 +1,256,988 | +30% | +$20.6M |
|
12
Neurocrine Biosciences
NBIX
$13.8B
| $87.5M | 1.2% | 2,199,505 +192,322 | +10% | +$7.65M |
|
|
13
Tenet Healthcare
THC
$16.3B
| $85.2M | 1.16% | 2,306,633 +1,917,250 | +492% | +$70.8M |
|
14
Healthcare Realty
HR
$6.11B
| $77.9M | 1.06% | 3,176,649 +294,550 | +10% | +$7.22M |
|
15
Align Technology
ALGN
$10.3B
| $77.7M | 1.06% | 1,369,034 +356,992 | +35% | +$20.3M |
|
16
Zimmer Biomet
ZBH
$21B
| $76.5M | 1.04% | 814,029 -188,429 | -19% | -$17.7M |
|
|
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
| $71.9M | 0.98% | 781,778 +30,955 | +4% | +$2.85M |
|
|
SIOX
18
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $66.7M | 0.91% | 5,159,160 +79,160 | +2% | +$1.02M |
|
19
Biogen
BIIB
$19.4B
| $65M | 0.89% | 222,802 +220,092 | +8,121% | +$64.2M |
|
20
Ultragenyx Pharmaceutical
RARE
$2.89B
| $60.8M | 0.83% | 631,053 -37,185 | -6% | -$3.58M |
|
|
AMRI
21
DELISTED
Albany Molecular Research Inc
AMRI
| $57.5M | 0.79% | 3,300,000 +100,000 | +3% | +$1.74M |
|
22
Zoetis
ZTS
$69.3B
| $48.1M | 0.66% | 1,169,262 +248,949 | +27% | +$10.3M |
|
|
CBPO
23
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $46.4M | 0.63% | 516,394 +16,135 | +3% | +$1.45M |
|
24
FibroGen
FGEN
$47.8M
| $44.1M | 0.6% | 2,011,100 +440,959 | +28% | +$9.67M |
|
|
XL
25
DELISTED
XL Group Ltd.
XL
| $44M | 0.6% | 1,210,885 +37,624 | +3% | +$1.37M |
|